跳至主要内容
临床试验/NCT06269029
NCT06269029已完成不适用

Effect of Chest Mobility Exercises Versus Proprioceptive Neuromuscular Facilitation in Patients With Chronic Obstructive Pulmonary Disease

Cairo University2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年2月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
Pulmonary function test

研究概览

简要总结

Chest mobility exercise versus proprioceptive neuromuscular facilitation in patients with chronic obstructive pulmonary disease

详细描述

The purpose of this study is designed to compare the therapeutic effect of chest mobility exercises and proprioceptive neuromuscular facilitation stretching on improving chest expansion and functional capacity in patients with chronicobstructivepulmonarydisease?

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
50 Years 至 60 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • All patients will have the following criteria:
  • Age: 50-60 years old
  • All patients will be in mild to moderate of COPD. In accordance with criteria of Global Initiative for Chronic Obstructive Lung Disease (GOLD) (GOLD I-II).
  • BMI: obese class 1 (30-34.9).
  • They suffered from mild dyspnea, chronic cough and expectorations, with forced expiratory volume in one second (FEV1sec) from 50% to 80% of predicted value.
  • Exclusion criteria:
  • Patients with the following criteria will excluded from the study:
  • Severe psychiatric or cognitive impairments.
  • Progressive neuromuscular disorders.
  • Decreased level of consciousness.
  • Unstable fracture.
  • pacemaker inserted for fewer than 2 days
  • Deep-venous thrombosis (to minimize risk for pulmonary embolism from being in a prone position.
  • Mean arterial blood pressure of less than 65 mm Hg with or without vasopressors.
  • Tracheal surgery or sternotomy in the last 15 days.
  • Massive haemoptysis.
  • Intracranial pressure of more than 30 mm Hg or cerebral perfusion pressure of less than 60 mm Hg.

排除标准

  • 未提供

结局指标

主要结局

Pulmonary function test

时间窗: One week for each comparator

Spirometry is the most common pulmonary function test. It is widely used in the assessment of lung function to provide objective information used in the diagnosis of lung diseases and monitoring lung health Test started at the time of 20 minutes after subjects inhaling 400 μg of salbutamol. The following variables were assessed: FVC, FEV1, inspiratory capacity (IC), and inspiratory reserve volume (IRV)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Isaac Zakaria Zarii Yanii

Doctor

Cairo University

研究点 (2)

Loading locations...

相似试验